Adjuvanted meningococcus compositions

Details for Australian Patent Application No. 2002334844 (hide)

International Classifications

Event Publications

13 February 2003 Complete Application Filed

Priority application(s): PCT/US02/10869 05.04.02 US; 60/380,677 13.05.02 US; PCT/US02/30423 24.09.02 US; 10/265,083 03.10.02 US; 60/373,547 17.04.02 US; 60/326,929 03.10.01 US; 10/254,438 24.09.02 US; 10/265,083 03.10.02 US; PCT/US02/31486 03.10.02 US

26 June 2003 Application Open to Public Inspection

Published as AU-B-2002334844

2 August 2007 Application Accepted

Published as AU-B-2002334844

23 August 2007 Corrigenda

Applications Accepted - Name Index Under the name Chiron Corporation, Application No. 2002334844, under INID (30), correct the priority detail Corrigenda to read PCT/US02/10869 US 5 Apr 2002; 60/380,677 US 13 May 2002; PCT/US02/30423 US 24 Sep 2002; 10/265,083 US 3 Oct 2002; 60/373,547 US 17 Apr 2002; 60/326,929 US 3 Oct 2001: 10/254,438 US 24 Sep 2002; PCT/US02/31486 US 3 Oct 2002

6 December 2007 Standard Patent Sealed

27 November 2008 Alteration of Name

The name of the patentee has been altered to Novartis Vaccines and Diagnostics, Inc. Amendments

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.